respimmun.at
• Böhm
• Brčić
• Heinemann
• Höfler
• Kargl
• Kwapiszewska
• Leithner
• Marsche
• Marsh
•Moissl-Eichinger
•Olschewski A
Olschewski H ⏩
• Strobl
• Tomazic
• Brčić
• Heinemann
• Höfler
• Kargl
• Kwapiszewska
• Leithner
• Marsche
• Marsh
•
•
Olschewski H ⏩
• Strobl
• Tomazic
The RESPImmun Faculty
|
Horst OLSCHEWSKI, MD, PhDCharacterization of the vascular phenotype in COPD: Are there gender differences? |
|
Department of Medicine, Division of Pulmonology, Medical University of Graz,
Auenbruggerplatz 15, A-8036 Graz;
| |
| websites: [RESPImmun] | |
| • Profile • Curriculum vitae ⏬ • PhD students • Grants • Publications | |
| ORCID-ID: | 0000-0002-2834-7466 |
| Research areas: | |
|---|---|
| Pulmonary hypertension, COPD, lung cancer, imaging, pulmonary artery, vasodilators, reverse remodelling | |
| 2002–2004 | Associate Professor, Department of Internal Medicine, Justus Liebig University Gieß |
| Career history: | |
| 2005–present | Full Professor and Director of the Division of Pulmonology, Department of Internal Medicine, Medical University of Graz |
| 2002, 2008 | Board certifications in Intensive Care Medicine, Infectious Diseases |
| 2000 | Habilitation in Pulmonology |
| 1994, 1999 | Board certifications in Internal Medicine, Pulmonology |
| 1988–1997 | Resident and Assistant Professor in Internal Medicine and Pulmonology, Justus Liebig University Hospital Gieß |
| 1986 | PhD thesis in Physiology, Justus Liebig University Gieß. |
| 1985–1988 | Research Fellow, Physiological Institute of the Medical Faculty, Justus Liebig University Gieß |
| 1978–1984 | Study of Human Medicine, MD, Justus Liebig University Gieß, Germany |
| Career-related activities (5 most important): | |
| 2010 | Co-founder of the Ludwig-Boltzmann-Institute for Lung Vascular Research, Graz |
| 2001–2007 | Member of the Scientific Leadership Counsel of the Pulmonary Hypertension Association, USA |
| 1998–2010 | International Steering Committee member of the AIR, TRIUMPH and ARIES studies |
| 1998–2018 | Delegate of the 2nd WHO Conference on Primary Pulmonary Hypertension in Evian, France 1998, and further of the respective conferences in Venice, 2003, Dana Point, 2008, Nice, 2013 and Nice, 2018 |
| 1996 | Design and performance of a German multicenter study with inhaled iloprost for the treatment of severe pulmonary hypertension (investigator IND) |
| Major honours and awards (3 most important): | |
| 2016 | Honorary Membership of the Hungarian Respiratory Society |
| 2000 | PHeV grant as Visiting Clinician at US Centers Of Excellence for pulmonary hypertension |
| 1987 | Carl-Oelemann-Award for the best Doctoral Thesis, State of Hessen, Germany |
| Patents: | |
| 2017 | Patent for non-invasive PH diagnostics by means of biomarkers |
| 2016 | Patent for non-invasive PH diagnostics by means of impedance cardiography |
| 2015 | Patent for non-invasive PH diagnostics by means of dynamic CT |
| 2007 | Patent for non-invasive measurement of pulmonary arterial pressure by means of MRI |
| 2004 | Patent for a novel therapy for pulmonary hypertension |